HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nelly Ziade Selected Research

Simian Acquired Immunodeficiency Syndrome

5/2024Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group.
12/2023Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohort.
1/2023COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey.
1/2023Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study.
12/2022COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nelly Ziade Research Topics

Disease

13COVID-19
05/2024 - 01/2022
8Autoimmune Diseases (Autoimmune Disease)
05/2024 - 10/2022
5Simian Acquired Immunodeficiency Syndrome
05/2024 - 12/2022
5Myositis (Idiopathic Inflammatory Myopathies)
01/2024 - 10/2022
5Psoriasis (Pustulosis Palmaris et Plantaris)
01/2023 - 04/2019
4Inclusion Body Myositis
01/2024 - 10/2022
4Rheumatic Diseases (Rheumatism)
12/2023 - 01/2023
3Fatigue
01/2024 - 01/2022
3Axial Spondyloarthritis
01/2023 - 04/2019
3Ankylosing Spondylitis
01/2023 - 01/2022
2Sacroiliitis
01/2023 - 01/2023
2Back Pain (Backache)
01/2023 - 01/2022
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2023 - 11/2018
2Low Back Pain (Lumbago)
01/2023 - 01/2023
2Inflammation (Inflammations)
01/2023 - 05/2020
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2024
1Poliomyelitis (Polio)
10/2023
1Mumps
10/2023
1Tetanus
10/2023
1Measles
10/2023
1Whooping Cough (Pertussis)
10/2023
1Diphtheria
10/2023
1Rubella (German Measles)
10/2023
1Dermatomyositis (Dermatopolymyositis)
05/2023
1Dyspnea (Shortness of Breath)
05/2023
1Immune System Diseases (Immune Disorders)
05/2023
1Muscular Diseases (Myopathy)
05/2023
1Polymyositis
05/2023
1Infections
01/2023
1Necrosis
01/2023
1Pain (Aches)
01/2023
1Fever (Fevers)
01/2023
1Systemic Scleroderma (Systemic Sclerosis)
01/2023
1Uveitis
01/2023
1Rheumatoid Arthritis
01/2023
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2023
1Chills
01/2023
1Psoriatic Arthritis
11/2022
1Fibromyalgia (Fibrositis)
05/2022
1Joint Diseases (Joint Disease)
01/2022
1Synovitis
01/2022
1Spontaneous Abortion (Miscarriage)
11/2018
1Eclampsia
11/2018
1Vasculitis (Vasculitides)
11/2018
1Colorectal Neoplasms (Colorectal Cancer)
12/2016

Drug/Important Bio-Agent (IBA)

13VaccinesIBA
05/2024 - 01/2022
11COVID-19 VaccinesIBA
05/2024 - 01/2023
3C-Reactive ProteinIBA
01/2023 - 01/2022
3HLA-B27 Antigen (HLA B27 Antigen)IBA
01/2023 - 04/2019
2Immunosuppressive Agents (Immunosuppressants)IBA
05/2023 - 01/2023
2Antimalarials (Antimalarial Agents)IBA
05/2023 - 01/2023
2BNT162 VaccineIBA
01/2023 - 10/2022
2HLA Antigens (Human Leukocyte Antigens)IBA
05/2022 - 04/2019
1GlucocorticoidsIBA
01/2024
1Ligases (Synthetase)IBA
05/2023
1Adrenal Cortex Hormones (Corticosteroids)IBA
05/2023
1Immunologic Factors (Immunomodulators)IBA
05/2023
1Intravenous Immunoglobulins (IVIG)FDA Link
05/2023
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2023
1Monoclonal AntibodiesIBA
01/2023
1AntibodiesIBA
01/2023
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2023
1ChAdOx1 nCoV-19IBA
01/2023
1Janus Kinase InhibitorsIBA
01/2023
1O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA
01/2023
1Interleukin-17 (Interleukin 17)IBA
01/2023
1Biomarkers (Surrogate Marker)IBA
11/2022
1SolutionsIBA
01/2022
1Guanosine Diphosphate (GDP)IBA
01/2022
1AutoantibodiesIBA
05/2020
1Phospholipids (Phosphatides)FDA LinkGeneric
11/2018
1Etanercept (Enbrel)FDA Link
12/2016